A osteoporosis is not a rare disease, the clinical picture of vertebral osteoporosis is often not clear [1] . Vertebral fractures differ from peripheral fractures: peripheral fractures are usually related to trauma and are almost always symptomatic, while vertebral fractures are often asymptomatic and usually occur during normal daily activities, like bending forward, lifting objects and stair climbing. In the case of a peripheral fracture, the shape of the bone on a radiograph is, after treatment, generally restored, while vertebral fractures lead to an irreversible loss of height of a vertebra. Peripheral fractures are an all-or-none phenomenon, while vertebral fracture deformities may worsen gradually, and often occur at the same site. Thus, diagnosing a peripheral fracture will seldom be a problem, while it may be difficult to decide whether a vertebral deformity on a radiograph results from an (asymptomatic) vertebral fracture or not.
The use of corticosteroids (Cs) is associated with osteoporosis [2] [3] [4] . In several studies in Cs-treated patients, fractures are scored as an endpoint [5] [6] [7] [8] .
Comparison of the data of these studies is difficult, since different definitions are used for fractures [5] [6] [7] [8] . Two major problems hamper scoring of vertebral fractures: (a) the absence of widely accepted criteria for identifying deformities in radiographs of the thoracolumbar spine; (b) the clinical relevance of vertebral deformities, without symptoms of an acute vertebral fracture. In this study, we compared the following four scoring methods for vertebral deformities: the semiquantitative Kleerekoper score [1] and three quantitative scores according to Minne (from Heidelberg [9] ), Melton (from the Mayo Clinic [10] ) and Raymakers (from Utrecht [11] ).
PATIENTS AND METHODS
All consecutive out-patients with rheumatoid arthritis (RA) (according to the 1987 criteria of the American College of Rheumatology), who were currently on Cs, were asked to participate in this study. A control group was formed from RA patients not treated with Cs (matched for age and gender).
A total of 52 cases and 52 controls were included out of 0700 patients with RA in our care. The following data were derived from the medical records of the patients: age, gender, menopausal status, height, duration of RA, ESR, rheumatoid factor test, ARA functional class (Steinbrocker), current daily prednisone dosage, cumulative dose of prednisone, and other relevant medication [calcium, vitamin D, fluoride, bisphosphonates, oestrogens and diseasemodifying anti-rheumatic drugs (DMARDs)]. Clinical manifestations of vertebral fractures were defined as a vertebral deformity that had resulted in clinical manifestations, leading to the prescription of therapy: bedrest and/or analgesics [8] . Lateral roentgenograms of the thoracic and lumbar spine were taken in both groups. In our hospital, a constant target-to-film distance of 105 cm is used. The centre of the radiation beam is aimed at the lower edge of the scapula (about Th8) for the thoracic spine and at the iliac crest for the lumbar spine. If the thoracolumbar region was not satisfactorily visualized, a third radiograph was taken aiming in between and, if necessary, a separate radiograph was taken aimed at L5.
The heights (anterior, middle, posterior) of all vertebrae from Th4 through L5 were carefully measured, with a ruler, by two observers (WL, ZJ), independently of each other, and the mean of these measurements was calculated. If there was a difference between the observers in height of a vertebra of q25%, the measurement was repeated. Following this procedure, no difference in height of q25% existed ultimately between the two investigators.
The method of Kleerekoper [1] All vertebrae from Th4 through L5 are scored on inspection with the naked eye and compared with the vertebra below and above: 0 (normal shape and dimensions); 1 (only endplate deformity: middle height Q85%); 2 (anterior wedge deformity: anterior height Q85%); 3 (compression deformity: all three heights Q85%).
The method of Minne [9] All heights (anterior, middle, posterior from Th4 to L5) are divided by the height (anterior, middle, posterior) of the fourth thoracic vertebra, resulting in relative heights which are compared with the relative heights of a reference group of 110 healthy persons. If a measured relative height is q15% lower than the mean relative height from the control group, this is considered to be a fracture. The sum of these differences in relative heights exceeding 15% forms the Spine Deformity Index (SDI).
The method of Melton [10] This method is based on radiographs of 200 healthy women aged 50 yr and over. A decrease in vertebral height of 15% or more in comparison with the mean value of the control group for that vertebra is regarded as a vertebral deformity. This results in adjustment factors for normally occurring variation in the spine, e.g. if the posterior height of Th9 is compared with the posterior height of Th10, a difference in height of 15% is not sufficient for diagnosing a vertebral deformity because the posterior height of Th9 is normally 2% less than Th10. A compression fracture is present if the posterior height is 15% (or more) smaller than the adjusted posterior height of either adjacent vertebra. Anterior wedge fracture and concavity fracture were scored by a decrease in anterior height and middle height of 15%.
The method of Raymakers [11] All heights are compared with a predicted value, based on a reference group and the age and length of the patient. A difference of 15% or more in one of the heights is regarded as a vertebral deformity (anterior, middle, posterior). The total score of the vertebral column is formed by summing up all these differences in height and is called the Spine Fracture Index (SFI).
Differences in the number of patients with vertebral deformities and the total number of vertebral deformities between the two groups were analysed with the Number Cruncher Statistical System (NCSS, version 5.1), using Fisher's exact tests for categorical data and Wilcoxon rank sum tests for continuous data (cq SDI scores) that were not normally distributed.
RESULTS
The study group of 52 Cs-treated RA patients consisted of seven men (13%) and 45 women (87%), of whom 42 (81%) were postmenopausal. The control group of 52 RA patients not treated with Cs also consisted of seven men and 45 women, of whom 40 (76%) were postmenopausal. There were no statistically significant differences in age, gender, percentage postmenopausal women, height, disease duration, ESR, presence of rheumatoid factor and functional status according to Steinbrocker (Table I) . No significant differences exist either in the number of patients using anti-osteoporotic drugs or in the number of patients using DMARDs.
Clinically manifest vertebral fractures occurred more often in the Cs-treated RA patients (n = 7; 13%) than in those not Cs treated (n = 1; 2%), although this difference was not significant [relative risk (RR) 7; 95% CI 0.89-54.9].
With the Kleerekoper score, vertebral deformities were found in 30 of the 52 Cs-treated patients (58%), while in the control group vertebral deformities were observed in 13 of the 52 RA patients Cs (25%) (RR 2.31; 95% CI 1.36-3.90). No statistically significant differences were found in the number of patients with vertebral deformities according to the three quantitative methods (Table II) .
The total number of vertebral deformities, calculated by the Kleerekoper score, was 87 in the Cs-treated (Table III) . Of all types of vertebral deformities (biconcave, wedge, crush), biconcave deformities were the most frequently observed in both groups. All three types occurred more often in the Cs-treated patients (Table IV) .
In 
DISCUSSION
It is important to detect vertebral deformities because patients with them are at high risk of further vertebral deformities [12, 13] . This risk varies from 5-to 12-fold, depending on the number of pre-existing deformities [13] . Decreased bone mass, defined as 2 .. below the mean, is also associated with a 3-to 6-fold increased risk of vertebral fractures [13, 14] . Thus, decreased bone mass as well as vertebral deformities may be considered as an indication for (further) prevention of osteoporosis.
Cs-treated RA patients are at high risk for fractures because both the use of Cs [5] [6] [7] [8] and the underlying disease [15, 16] are associated with fractures. Thus, screening for vertebral deformities in Cs-treated RA patients may be useful. Several methods exist for scoring vertebral deformities, each with its own disadvantages. Each method that does not take into account the normal shape (thoracic slightly wedge shaped, lumbar slightly inverse wedge shaped) of the vertebrae, like the Kleerekoper method, will lead to fracture rates that are (slightly) inaccurate. However, a semiquantitative method, like the Kleerekoper score, is simple to work with, not time consuming, and therefore useful in daily practice. Recently, it was shown that the inter-reader reproducibility of the semiquantitative approach, in the hands of experienced and trained readers, has a high degree of reliability for the identification of vertebral deformities [17] .
The methods of Melton and Minne are based on X-rays of healthy postmenopausal women. Because vertebral deformities may occur asymptomatically, it is possible that the reference groups in the studies of Melton and Minne contain patients with osteoporotic vertebral deformities. Thus, it is not unreasonable to suggest that vertebral deformities may be underscored by these methods. The methods of Kleerekoper and Melton also have the disadvantage that they miss crush fractures if they occur in a row, because in this method the vertebrae above and beneath the vertebra to be scored are the reference vertebrae, and therefore these vertebrae will be considered to be normal. The method of Minne has the disadvantage that if Th4 is fractured or its heights are measured inadequately, this will have consequences for the entire spine as all other vertebral heights are related to the measured height of Th4. Recently [18] , it was shown that the vertebral deformity rate according to the method of Minne has a weaker correlation with clinical criteria (like bone mass and height loss) than three other quantitative scoring methods.
Comparing Cs-treated RA patients with those not Cs treated, the total number of vertebral deformities was significantly higher according to the semiquantitative Kleerekoper score and to the quantitative scores according to Minne and Raymakers. In contrast, the number of patients with vertebral deformities (prevalence) was higher only according to the Kleerekoper score. This clearly illustrates that methods for measuring vertebral deformities differ substantially.
In population-based studies, the reported prevalence of women with vertebral deformities varies widely from 6.6% [19] to 27% [10] , which might be due to differences in the definition of vertebral deformity and different reference ranges between centres [20] . We observed an increased prevalence of vertebral deformities, in comparison to data from the literature [10, 19] , in both groups: in the Cs-treated RA patients the prevalence of patients with vertebral deformities varies from 35% (Melton) to 79% (Minne) , and in the control group from 25% (Kleerekoper) to 67% (Minne) . These results illustrate that the prevalence of vertebral deformities is increased not only in Cs-treated RA patients, but also in RA patients not Cs treated.
In the large European Vertebral Osteoporosis Study, wedge deformities are the most frequently observed vertebral deformities [21] . In the present study, biconcave deformities were the most frequently observed deformities (in both patient groups). All three types of deformities (biconcave, wedge, crush) are observed more often in the Cs-treated patients. This probably reflects increased bone loss at the whole vertebra, induced by the use of Cs and the underlying disease for which Cs are prescribed.
Recently, new data appeared on measuring vertebral deformities, in which reference values are defined as the deviation from the mean in ..: a difference of 3 .. below the mean is comparable with height loss of 15% [22, 23] and a difference of 4 .. with 25% [23] . These recently performed studies are quite large: Black et al. [22] defined reference data for normal vertebral heights based on radiographs of 2992 women.
The clinical importance of vertebral deformities is not only based on loss of height, but also on clinical symptomatology. In postmenopausal women, the incidence of vertebral deformities was 17.8/1000 person-years, while the incidence of clinically diagnosed vertebral fractures was 5.3/1000 person-years [24] . This difference is also observed in the present study: only seven out of 52 (13%) Cs-treated RA patients had suffered from clinically manifest vertebral fractures, while vertebral deformities had occurred more often (35-79%, depending on the scoring method used). In the patients not treated with Cs, a difference was also observed: 1 (2%) vs 25-67%. These data support the view that although vertebral fractures lead to vertebral deformities, not all vertebral deformities are caused by vertebral fractures [25] . Other causes of decreased vertebral height without osteoporosis are M Scheuermann and, recently described, thoracic spondylarthropathy [26] .
Of the patients with clinically diagnosed vertebral fractures, 80% had a deformation of 4 .. or more [24] . This is in accordance with the present study, in which all eight patients with clinically manifest vertebral fractures had vertebrae with 25% height loss or more.
One essential difference in the SDI, compared with other scores [1, 9-11, 22, 23] , is that the sums of decreases in heights exceeding the limit of 15% height loss are added. This indicates that vertebral height losses of 17 and 27% are both counted as one vertebral deformity, but as 2 and 12%, respectively, for the SDI. Because both clinical manifestations in the acute phase [24] and chronic back pain with disability and height loss [27, 28] predominantly occur in patients with more severe vertebral deformities, in our opinion a gold standard or consensus for vertebral deformities should not only include the number of vertebrae with dimensions below a limit, but also the magnitude of the difference.
In summary: vertebral deformities occur more often in Cs-treated RA patients than in those not Cs treated. However, differences exist in the number of patients with vertebral deformities and in the total number of vertebral deformities depending on the scoring method used. This emphasizes that for defining vertebral deformities a gold standard or consensus is needed, in which, in our opinion, an SDI should be included because the SDI correlates well with quality of life as predominantly the severe deformities give rise to symptoms. Clinically manifest vertebral fractures are predominantly caused by severe vertebral deformities. For daily practice, the Kleerekoper score is an easy method to assess vertebral deformities.
